XML 53 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
GENERAL (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Aug. 05, 2013
Jan. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 18, 2023
Dec. 31, 2022
Nov. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]              
Net loss     $ (14,231) $ (18,754)   $ (33,694)  
Accumulated deficit     (488,758) (474,527)      
Net cash used in operating activities     49,604 $ (35,886)   $ (34,113)  
Non-refundable upfront payment         $ 60,000,000    
Milestone payment         30,000,000    
Potential milestone compensation company is now eligible for         $ 758,000,000    
Preclinical milestone compensation $ 23,200            
Amount of investment in Compugen     12,000       $ 20,000
Upfront payment received $ 10,000   10,000        
Accrued milestone payment     30,500        
Potential milestone compensation     $ 200,000        
Percentage of expected from payment amount paid   15.00%